OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC

NCT03806309 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma
Locally Advanced Cancer
Metastatic Cancer

Interventions

DRUG: FOLFIRI
DRUG: OSE2101

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group

Collaborators

[object Object]